Countering hepatitis B virus infection using RNAi: how far are we from the clinic?
about
Progress and Prospects of Anti-HBV Gene Therapy DevelopmentLipid nanoparticles as carriers for RNAi against viral infections: current status and future perspectivesHepatitis B virus and microRNAs: Complex interactions affecting hepatitis B virus replication and hepatitis B virus-associated diseasesSustained Inhibition of HBV Replication In Vivo after Systemic Injection of AAVs Encoding Artificial Antiviral Primary MicroRNAs.Inhibition of hepatitis B virus replication by helper dependent adenoviral vectors expressing artificial anti-HBV pri-miRs from a liver-specific promoter.Novel approaches to flavivirus drug discovery.Studies of efficacy and liver toxicity related to adeno-associated virus-mediated RNA interference.Recent advances in developing nucleic acid-based HBV therapy.The state of gene therapy research in Africa, its significance and implications for the future.Gene Therapy for Chronic HBV-Can We Eliminate cccDNA?
P2860
Q26799228-59442DA3-24AF-4CBA-BB39-06D2E8BCD7FFQ26859021-2D537653-1DDB-4B6E-9153-5B4368377A72Q27024630-5555E7BF-6F35-4E66-A0A2-6BE7B79C6C5AQ33635361-8481888A-54EE-4F2A-B101-CF748F3BC6C1Q33791557-D59CB843-06F9-4B88-8B34-0A566DC7ECFAQ34206832-C5912ADE-9F28-46F9-B431-3CE8D233B6C9Q37105696-5561DE4E-8F7F-43DF-9570-87ABE6BCC3C6Q38160538-5EF3512A-B0D6-4827-88C6-0DCD77ED6CF2Q38660339-3D35334A-5B27-40B0-A852-EE0E0D18434EQ52431500-F555ABE8-656C-44C4-9D86-D2016D341706
P2860
Countering hepatitis B virus infection using RNAi: how far are we from the clinic?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Countering hepatitis B virus infection using RNAi: how far are we from the clinic?
@en
Countering hepatitis B virus infection using RNAi: how far are we from the clinic?
@nl
type
label
Countering hepatitis B virus infection using RNAi: how far are we from the clinic?
@en
Countering hepatitis B virus infection using RNAi: how far are we from the clinic?
@nl
prefLabel
Countering hepatitis B virus infection using RNAi: how far are we from the clinic?
@en
Countering hepatitis B virus infection using RNAi: how far are we from the clinic?
@nl
P2093
P2860
P356
P1476
Countering hepatitis B virus infection using RNAi: how far are we from the clinic?
@en
P2093
Abdullah Ely
Dejana Ivacik
Patrick Arbuthnot
P2860
P304
P356
10.1002/RMV.705
P577
2011-09-13T00:00:00Z